![](https://investorshub.advfn.com/uicon/441924.png?cb=1545404645)
Friday, January 02, 2015 7:10:48 PM
Hargrove told me that they were rethinking the way they will release info and I still believe this quarter will be a tell tail sign of how this will be dealt with until marketing approval occurs.
Based on the fact that there is a milestone to be hit this quarter regarding the prototype I expect and anticipate that the stock will trade up on anticipation of this and it better be on time in my opinion.
I've been doing this for 30 years I'm not a medical profession but an Wall Street guy turned trader/investor.
I realize you know a lot about medicine and the operating room but I have greater experience when it comes to his type of thing.
Also those that did the secondary will be looking for a return on their 37mm and thus far they are down and Hargrove will have to answer to them for sure.
My point was in fact similar to yours, if you can't stand the heat get out of the kitchen, so based on this the so called "real deal" needs to fly.
Great weekend and we will prevail and make huge gains with this one.
Believe that!
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM